Being the first dual GLP-1/GIP receptor agonist to be approved in clinical practice, tirzepatide has better efficacy than the conventional GLP-1 monotherapy
Preclinical evidence in transgenic models of Alzheimers disease suggests that liraglutide exerts neuroprotective effects by reducing amyloid oligomers, normalising synaptic plasticity and cerebral glucose uptake, and increasing the proliferation of neuronal progenitor cells
This is due to the main component of products - glutathione, which is a very powerful antioxidant that helps to improve the protective properties of the skin, preventing free radicals and the negative effects of bad ecology, wind, rain, snow, cold and daily stress
1 BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer SOURCE Quest Diagnostics
Sanz AB, Ruiz-Andres O, Sanchez-Nio MD, Ruiz-Ortega M, Ramos AM, Ortiz A
J Mol Model 30 , 181 (2024)